Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial
Version 2 2024-06-04, 05:38
Version 1 2022-11-08, 02:33
journal contribution
posted on 2024-06-04, 05:38 authored by PJ Mitchell, B Yan, L Churilov, RJ Dowling, SJ Bush, A Bivard, XC Huo, G Wang, SY Zhang, MD Ton, DJ Cordato, TJ Kleinig, H Ma, RV Chandra, H Brown, BCV Campbell, AK Cheung, B Steinfort, R Scroop, K Redmond, F Miteff, Y Liu, DP Duc, H Rice, MW Parsons, TY Wu, HT Nguyen, GA Donnan, ZR Miao, Hamed AsadiHamed Asadi, X SongEndovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial
History
Related Materials
- 1.
Location
Amsterdam, The NetherlandsLanguage
engPublication classification
C1 Refereed article in a scholarly journalJournal
The LancetVolume
400Season
9 - 15 July 2022Pagination
116-125ISSN
0140-6736eISSN
1474-547XIssue
10346Publisher
ElsevierUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC